We identified 447 DEGs (fold change >1.5, p value <0.05), 176 up-regulated and 271 down-regulated, in the BRCA1-deficient ovarian cancer patients (Figure 3A). This evidence concerns the gene BRCA1 and ovarian carcinoma.